Image: Pexels

Opioid use in pregnancy has risen dramatically in recent years.

One study found an alarming increase in the number of infants born to opioid-dependent women in Ontario — from 46 in 2002 to almost 800 in 2014. Up to 80 per cent of these infants will go on to develop neonatal opioid withdrawal syndrome (NOWS), a constellation of clinical signs that usually arise within 72 hours of delivery.

These infants experience tremors, a high-pitched cry, uncoordinated sucking, diarrhea and vomiting. This usually abates within 10 to 14 days of life. Whether NOWS impacts the long term health and development of infants is currently unclear but is an active area of ongoing research.

To date, infants diagnosed with NOWS have largely been managed in neonatal intensive care units (NICUs) across the country. However, in light of significant evidence supporting its safety and effectiveness, management of NOWS is shifting towards care that keeps infants and their mothers together, called “rooming-in.”

Babies show less severe symptoms

Substantial research over the past decade shows that rooming-in is associated with many positive outcomes for opioid-exposed mothers and their infants compared to NICU-based care.

Benefits include improved mother-infant bonding, greater chances of breastfeeding, less severe NOWS, less medication for the newborn and much shorter hospital stays.

Further, some of these studies show that babies who room-in may have a greater chance of remaining in their mother’s custody at discharge.

Stigma towards opioid-using women

Supporting evidence for the practice of rooming-in dates back over 10 years. Based on my experience working to establish a rooming-in program in my own health region, I hypothesize that the lack of established programs may be due to other barriers. These include concerns about where to locate a rooming-in program, given significant bed shortages on maternity and pediatric units.

They also include discomfort among care providers about monitoring postpartum mothers with opioid dependence and babies with NOWS in a ward setting — as well as ongoing stigma associated with opioid use in pregnant women, which leads to care-provider concerns about the safety of an infant remaining in the mother’s care.

We must be innovative and tireless

I realise there will be unique challenges and barriers faced at each hospital looking to implement rooming-in care for opioid exposed mothers and their newborns, however we cannot be paralysed into inaction as a result.

We must work together to overcome these challenges in the name of providing family-focused care to opioid-dependent mothers and their babies. This will ensure the best possible outcomes, with the added benefits of de-escalating care (for instance, keeping care outside the NICU when possible) and cost savings due to shortened stays in hospital.

We must be innovative and tireless within our individual health regions to ensure rooming-in programs are available across Canada. These infants, along with their newly postpartum mothers, deserve the best evidence-based care we can offer.

The Conversation

The Conversation